Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Czerniak

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
The American Journal of Surgical Pathology|November 22, 2001
Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomasS H Merchant, M B Amin, P Tamboli, et al.
Nature Genetics|January 1, 2004
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53Hiroshi Katayama, Kaori Sasai, Hidehiko Kawai, et al.
Journal of Clinical Pathology|September 29, 2005
H19 expression in hepatic metastases from a range of human carcinomasY Fellig, I Ariel, P Ohana, et al.
Journal of Oncology|November 6, 2010
Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic CancerV Scaiewicz, V Sorin, Y Fellig, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 2008
Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcomaWei-Lien Wang, Empar Mayordomo, Bogdan A Czerniak, et al.
Cancer|July 7, 2007
Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experienceWassim Kassouf, Philippe E Spiess, Arlene Siefker-Radtke, et al.
Urologic Oncology|February 20, 2019
Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinomaJonathan J Duplisea, Firas G Petros, Roger Li, et al.
Oncotarget|October 8, 2016
RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulationJianqi Yang, Lance T Platt, Biswanath Maity, et al.
Cancer Gene Therapy|July 24, 2002
Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancerMotoyuki Yamashita, Charles J Rosser, Jain-Hua Zhou, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 2, 2011
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancerAnita L Sabichi, J Jack Lee, H Barton Grossman, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
The American Journal of Surgical Pathology|November 22, 2001
Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomasS H Merchant, M B Amin, P Tamboli, et al.
Nature Genetics|January 1, 2004
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53Hiroshi Katayama, Kaori Sasai, Hidehiko Kawai, et al.
Journal of Clinical Pathology|September 29, 2005
H19 expression in hepatic metastases from a range of human carcinomasY Fellig, I Ariel, P Ohana, et al.
Journal of Oncology|November 6, 2010
Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic CancerV Scaiewicz, V Sorin, Y Fellig, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 2008
Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcomaWei-Lien Wang, Empar Mayordomo, Bogdan A Czerniak, et al.
Cancer|July 7, 2007
Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experienceWassim Kassouf, Philippe E Spiess, Arlene Siefker-Radtke, et al.
Urologic Oncology|February 20, 2019
Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinomaJonathan J Duplisea, Firas G Petros, Roger Li, et al.
Oncotarget|October 8, 2016
RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulationJianqi Yang, Lance T Platt, Biswanath Maity, et al.
Cancer Gene Therapy|July 24, 2002
Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancerMotoyuki Yamashita, Charles J Rosser, Jain-Hua Zhou, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 2, 2011
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancerAnita L Sabichi, J Jack Lee, H Barton Grossman, et al.
Pageof 15